Evidence map›Paper›PMID 34251590›Full record

ReviewPurinergic signalling2021

Pannexin 1 as a driver of inflammation and ischemia-reperfusion injury.

Michael Koval, Aleksandra Cwiek, Thomas Carr, Miranda E Good, Alexander W Lohman, Brant E Isakson

Open access · bronzeAbstract readReview
In one paragraph

Review in Purinergic signalling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pannexins in the vasculature.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. PANX1 hexamers work but cells prefer heptamers.The Journal of general physiology · 2025
    Article
  11. Novel Naphthyridones Targeting Pannexin 1 for Colitis Management.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Role of astrocytes connexins - pannexins in acute brain injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Michael KovalDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, 205 Whitehead Building, 615 Michael Street, Atlanta, GA, 30322, USA. mhkoval@emory.edu.ORCID 0000-0002-5422-5614
Aleksandra CwiekDepartment of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA.
Thomas CarrDepartment of Cell Biology and Anatomy, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
Miranda E GoodMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, USA.
Alexander W LohmanDepartment of Cell Biology and Anatomy, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
Brant E IsaksonRobert M. Berne Cardiovascular Research Center, School of Medicine, University of Virginia, PO Box 801394, Charlottesville, VA, 22908, USA. brant@virginia.edu.ORCID 0000-0002-7692-6294
University of Calgary · CAUniversity of Virginia · USEmory University · USTufts Medical Center · US

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI LEITINGER, NORBERT · 2014 to 2023
$24.0M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Purinergic Regulation of Veinous Endothelial PermeabilityR01HL137112 · NHLBI · UNIVERSITY OF VIRGINIA · PI Brant E Isakson, MICHAEL H. KOVAL · 2018 to 2026
$4.7M
Vascular Pannexin 1 in Ischemic StrokeR00HL143165 · NHLBI · TUFTS MEDICAL CENTER · PI GOOD, MIRANDA E · 2020 to 2022
$747k
Vascular Pannexin 1 in Ischemic StrokeK99HL143165 · NHLBI · UNIVERSITY OF VIRGINIA · PI GOOD, MIRANDA E · 2018 to 2019
$206k
NHLBI NIH HHS K99 HL143165NHLBI NIH HHS R00 HL143165NHLBI NIH HHS R01 HL137112NHLBI NIH HHS T32 HL007284
6 · The paper itself

Abstract

Pannexin 1 (Panx1) is a ubiquitously expressed protein forming large conductance channels that are central to many distinct inflammation and injury responses. There is accumulating evidence showing ATP released from Panx1 channels, as well as metabolites, provide effective paracrine and autocrine signaling molecules that regulate different elements of the injury response. As channels with a broad range of permselectivity, Panx1 channels mediate the secretion and uptake of multiple solutes, ranging from calcium to bacterial derived molecules. In this review, we describe how Panx1 functions in response to different pro-inflammatory stimuli, focusing mainly on signaling coordinated by the vasculature. How Panx1 mediates ATP release by injured cells is also discussed. The ability of Panx1 to serve as a central component of many diverse physiologic responses has proven to be critically dependent on the context of expression, post-translational modification, interacting partners, and the mode of stimulation.

Indexed as

Adenosine TriphosphateAnimalsConnexinsHumansInflammationNerve Tissue ProteinsReperfusion InjurySignal TransductionAdenosine TriphosphateConnexinsNerve Tissue ProteinsInflammationPannexin 1Purinergic signaling

Identifiers

PMID34251590
PMCPMC8273370
OpenAlexW3178561779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.